Royal Brompton & Harefield is one of Europe’s largest centres for the diagnosis and treatment of heart disease. We are internationally recognised as leaders in the development of minimally invasive therapy for coronary heart disease.
A series of new appointments has strengthened cardiology services in the past year. Dr Wajid Hussain, consultant cardiologist, joined the Harefield electrophysiology team in October 2007, an appointment which has enabled the significant expansion of the service. Cardiac imaging at Harefield also continues to develop thanks to the appointment of Dr Shelley Rahman Haley who specialises in echocardiography and cardiac magnetic resonance.
Harefield’s primary angioplasty centre continues to offer patients in outer north-west London a gold standard service. At the British Cardiovascular Society’s Annual Scientific Conference in June, consultant cardiologist Miles Dalby and colleagues presented new research to show the benefits of primary angioplasty for some heart attack patients.
Dr Dalby and his colleagues compared patients who received primary angioplasty at Harefield to those who received traditional clot busting treatment (thrombolysis) in an A&E department. They found that patients who had been taken to Harefield and treated with angioplasty – in which a tube is passed into the heart and a small balloon inflated to open up blocked vessels – had significantly better outcomes than patients who had received thrombolysis.
“It was very reassuring to have the
arrhythmia nurse specialist contact me
before my first admission, visit me on
the ward and contact me after admission.
She took away my fears and anxiety.”
At Royal Brompton, Dr Sabine Ernst joined the team in late 2007 as consultant cardiologist, honorary senior lecturer and lead for electrophysiology research.
Dr Ernst is an internationally recognised expert in magnetic navigation and has overseen the introduction of a new magnetic navigation laboratory at Royal Brompton. The new system allows our consultants to carry out complex catheter-based procedures almost entirely by remote control, allowing greater accuracy and reducing radiation exposure for both staff and patients.
The new lab is the most advanced of its kind in Europe and will benefit patients with complex congenital heart defects and arrhythmias. As well as advancing clinical practice in the UK, the new lab will allow experts at the Trust to pioneer important new research projects in 3D imaging and morphology, which should lead to the development of new invasive cardiac procedures to the ultimate benefit of patients internationally.